RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer

Ning Li(Shenyang Pharmaceutical University), Hua‐chuan Zheng(Jinzhou Medical University)
Frontiers in Pharmacology
April 22, 2025
Cited by 1


Related Papers